paclitaxel has been researched along with Dysphagia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Koo, P; Malin, M; Okereke, J | 1 |
| Bonaventura, A; Day, F; Holt, B; Kumar, M; Loh, J; Lynam, J; Mandaliya, H; Martin, J; Smart, J; Sridharan, S | 1 |
| Cui, X; Hu, Y; Jiao, S; Liu, M; Luo, H; Pan, C; Song, Z; Wu, D; Wu, L; Xu, Q; Yang, B; Yuan, J; Zhang, G; Zhang, J | 1 |
| Anker, CJ; Francis, SR; Lloyd, S; Orton, A; Stoddard, G; Thorpe, C | 1 |
| Eich, HT; Elsayad, K; Haverkamp, U; Maring, S; Rehkämper, J; Rudack, C; Stenner, M; Wardelmann, E | 1 |
| Hirano, A; Inoue, H; Kinoshita, J; Kodera, A; Matsuoka, A; Naritaka, Y; Ogura, K; Sakaguchi, S; Tanaka, N; Yoshimatsu, K; Yukawa, H | 1 |
| Barringer, DA; Garden, AS; Holsinger, FC; Hutcheson, KA; Kies, MS; Lewin, JS; Lin, HY; Lisec, A; Papadimitrakopoulou, V; Steinhaus, G; Villalobos, S | 1 |
| Bottomley, A; Coens, C; Ediebah, DE; Flechtner, H; Gotay, C; Greimel, E; King, MT; Quinten, C; Reeve, BB; Ringash, J; Schmucker von Koch, J; Smit, EF; Taphoorn, MJ; Weis, J; Zikos, E | 1 |
| Browne, JD; D'Agostino, RB; Greven, KM; McGuirt, WF; White, DR; Williams, DW | 1 |
| DuVall, GA; Elstad, NL; Fowers, KD; Seidel, RH; Tarabar, D | 1 |
| Berger, DP; Chen, Y; Krzakowski, MJ; Lizambri, R; Massuti, B; Otterson, GA; Schuette, W; Wei, H | 1 |
| Beller, E; Bessell, JR; Burmeister, BH; Burmeister, E; Doyle, L; Gotley, DC; Harvey, JA; Martin, I; Smithers, BM; Thomas, J; Thomson, DB; Walpole, ET | 1 |
| Axelrod, R; Byhardt, R; Komaki, R; Langer, C; Machtay, M; Movsas, B; Nicolaou, N; Sarna, L; Scott, C; Smith, C; Wasserman, T; Werner-Wasik, M | 1 |
| Minsky, BD | 1 |
| Dickson, J; Lyn, BE; Rojas, AM; Saunders, MI; Shah, N; Williams, FJ; Wilson, EM | 1 |
| Cannon, M; Cmelak, AJ; Forastiere, AA; Gillison, M; Goldwasser, MA; Li, S; Murphy, B; Pinto, H; Rosenthal, DI | 1 |
1 review(s) available for paclitaxel and Dysphagia
| Article | Year |
|---|---|
Primary combined-modality therapy for esophageal cancer.
Topics: Algorithms; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Dose Fractionation, Radiation; Esophageal Neoplasms; Fluorouracil; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
9 trial(s) available for paclitaxel and Dysphagia
| Article | Year |
|---|---|
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer.
Topics: Carboplatin; Chemoradiotherapy; Deglutition Disorders; Esophageal Neoplasms; Humans; Paclitaxel; Palliative Care; Stomach Neoplasms | 2022 |
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Deglutition Disorders; Ecosystem; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Multiomics; Neoadjuvant Therapy; Paclitaxel | 2023 |
Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Deglutition Disorders; Female; Gastrostomy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant | 2014 |
Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer.
Topics: Aged; Combined Modality Therapy; Deglutition Disorders; Delayed-Action Preparations; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome | 2009 |
Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Deglutition Disorders; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Fibroblast Growth Factor 7; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Severity of Illness Index; Treatment Outcome | 2012 |
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Deglutition Disorders; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Palliative Care; Prospective Studies; Radiation Dosage; Radiotherapy, Adjuvant; Stents; Treatment Outcome | 2004 |
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
Topics: Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deglutition Disorders; Dose Fractionation, Radiation; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Radiation Injuries; Radiation-Protective Agents; Survival Analysis; Treatment Outcome | 2005 |
Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Female; Humans; Leukocyte Count; Lung; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Platelet Count; Radiotherapy Dosage; Radiotherapy, Conformal; Treatment Outcome | 2006 |
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Deglutition Disorders; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Pharyngectomy; Platinum; Radiotherapy, Adjuvant; Recovery of Function; Salvage Therapy; Speech Disorders; Taxoids; Treatment Outcome | 2007 |
6 other study(ies) available for paclitaxel and Dysphagia
| Article | Year |
|---|---|
A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
Topics: Adult; Antineoplastic Agents; Asthma; Carboplatin; Cesarean Section; Cyclin-Dependent Kinase Inhibitor p16; Deglutition Disorders; Diagnosis, Differential; Female; Hoarseness; Humans; Laryngeal Neoplasms; Laryngoscopy; Paclitaxel; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Toxicity and Outcomes in Patients With and Without Esophageal Stents in Locally Advanced Esophageal Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chi-Square Distribution; Cisplatin; Deglutition Disorders; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Propensity Score; Regression Analysis; Retrospective Studies; Stents; Treatment Outcome | 2017 |
Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Deglutition Disorders; Disease-Free Survival; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2018 |
[Bevacizumab plus Paclitaxel Therapy Was Effective for Metastatic Breast Cancer with Dysphagia Due to Mediastinal Lymph Node Metastasis-A Case Report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Deglutition Disorders; Female; Humans; Lymph Nodes; Paclitaxel; Quality of Life | 2018 |
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deglutition Disorders; Deoxycytidine; Gemcitabine; Humans; Interpersonal Relations; Lung Neoplasms; Multicenter Studies as Topic; Nausea; Paclitaxel; Pain; Palliative Care; Prognosis; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Surveys and Questionnaires; Survival Analysis | 2014 |
Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Risk Factors | 2008 |